213 related articles for article (PubMed ID: 23922215)
1. Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy.
Huang YS; Lu HL; Zhang LJ; Wu Z
Med Res Rev; 2014 May; 34(3):532-66. PubMed ID: 23922215
[TBL] [Abstract][Full Text] [Related]
2. Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
van Waarde A; Rybczynska AA; Ramakrishnan NK; Ishiwata K; Elsinga PH; Dierckx RA
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2703-14. PubMed ID: 25173780
[TBL] [Abstract][Full Text] [Related]
3. S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling.
Ahmed IS; Chamberlain C; Craven RJ
Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):361-70. PubMed ID: 22292588
[TBL] [Abstract][Full Text] [Related]
4. Early development of sigma-receptor ligands.
Narayanan S; Bhat R; Mesangeau C; Poupaert JH; McCurdy CR
Future Med Chem; 2011 Jan; 3(1):79-94. PubMed ID: 21428827
[TBL] [Abstract][Full Text] [Related]
5. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy.
Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG
Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687
[TBL] [Abstract][Full Text] [Related]
6. Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy.
Megalizzi V; Le Mercier M; Decaestecker C
Med Res Rev; 2012 Mar; 32(2):410-27. PubMed ID: 20687157
[TBL] [Abstract][Full Text] [Related]
7. Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection.
Bhuiyan MS; Fukunaga K
Expert Opin Ther Targets; 2011 Feb; 15(2):145-55. PubMed ID: 21204730
[TBL] [Abstract][Full Text] [Related]
8. Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands.
van Waarde A; Rybczynska AA; Ramakrishnan N; Ishiwata K; Elsinga PH; Dierckx RA
Curr Pharm Des; 2010; 16(31):3519-37. PubMed ID: 21050178
[TBL] [Abstract][Full Text] [Related]
9. Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines.
Palmer CP; Mahen R; Schnell E; Djamgoz MB; Aydar E
Cancer Res; 2007 Dec; 67(23):11166-75. PubMed ID: 18056441
[TBL] [Abstract][Full Text] [Related]
10. Sigma-2 receptor and progesterone receptor membrane component 1 (PGRMC1) are two different proteins: Proofs by fluorescent labeling and binding of sigma-2 receptor ligands to PGRMC1.
Pati ML; Groza D; Riganti C; Kopecka J; Niso M; Berardi F; Hager S; Heffeter P; Hirai M; Tsugawa H; Kabe Y; Suematsu M; Abate C
Pharmacol Res; 2017 Mar; 117():67-74. PubMed ID: 28007569
[TBL] [Abstract][Full Text] [Related]
11. [Physiological function of sigma receptors: central pharmacological effects of sigma ligands].
Nabeshima T; Okuyama S
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Apr; 14(2):51-76. PubMed ID: 8042346
[TBL] [Abstract][Full Text] [Related]
12. Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site.
Xu J; Zeng C; Chu W; Pan F; Rothfuss JM; Zhang F; Tu Z; Zhou D; Zeng D; Vangveravong S; Johnston F; Spitzer D; Chang KC; Hotchkiss RS; Hawkins WG; Wheeler KT; Mach RH
Nat Commun; 2011 Jul; 2():380. PubMed ID: 21730960
[TBL] [Abstract][Full Text] [Related]
13. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.
Crawford KW; Bowen WD
Cancer Res; 2002 Jan; 62(1):313-22. PubMed ID: 11782394
[TBL] [Abstract][Full Text] [Related]
14. Sigma receptors and cancer: possible involvement of ion channels.
Aydar E; Palmer CP; Djamgoz MB
Cancer Res; 2004 Aug; 64(15):5029-35. PubMed ID: 15289298
[TBL] [Abstract][Full Text] [Related]
15. Effects of linker elongation in a series of N-(2-benzofuranylmethyl)-N'-(methoxyphenylalkyl)piperazine σ₁ receptor ligands.
Moussa IA; Banister SD; Akladios FN; Chua SW; Kassiou M
Bioorg Med Chem Lett; 2011 Oct; 21(19):5707-10. PubMed ID: 21871797
[TBL] [Abstract][Full Text] [Related]
16. Sigma-2 receptor: past, present and perspectives on multiple therapeutic exploitations.
Abate C; Niso M; Berardi F
Future Med Chem; 2018 Aug; 10(16):1997-2018. PubMed ID: 29966437
[TBL] [Abstract][Full Text] [Related]
17. Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line.
Ganapathy ME; Prasad PD; Huang W; Seth P; Leibach FH; Ganapathy V
J Pharmacol Exp Ther; 1999 Apr; 289(1):251-60. PubMed ID: 10087012
[TBL] [Abstract][Full Text] [Related]
18. NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profile.
Karbon EW; Abreu ME; Erickson RH; Kaiser C; Natalie KJ; Clissold DB; Borosky S; Bailey M; Martin LA; Pontecorvo MJ
J Pharmacol Exp Ther; 1993 May; 265(2):866-75. PubMed ID: 8388461
[TBL] [Abstract][Full Text] [Related]
19. Sigma-2 ligands induce tumour cell death by multiple signalling pathways.
Zeng C; Rothfuss J; Zhang J; Chu W; Vangveravong S; Tu Z; Pan F; Chang KC; Hotchkiss R; Mach RH
Br J Cancer; 2012 Feb; 106(4):693-701. PubMed ID: 22251921
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands.
Hornick JR; Spitzer D; Goedegebuure P; Mach RH; Hawkins WG
Surgery; 2012 Sep; 152(3 Suppl 1):S152-6. PubMed ID: 22763259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
